- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03144180
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques (qcup)
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques: A Feasibility Study
Studieoversikt
Detaljert beskrivelse
Approximately 4 million babies were born in the United States in 2015. Umbilical cord blood (UBC) collection is a routine hospital procedure done to evaluate a newborn's health after the birth of the fetus. UBC is tested to measure bilirubin levels, blood gases, blood sugar levels, blood types, complete blood counts, and platelet counts. UBC is collected by either draining the blood into the collection vial, milking the umbilical cord of blood, or extracting the blood by injecting a needle with a syringe. The Center for Disease Control (CDC) estimates 5.6 million workers in the health care industry are at risk of occupational exposure to bloodborne pathogens. Occupational exposure during umbilical cord blood collection may occur due to the great deal of blood and amniotic fluid present at the time of delivery. This fluid causes the physician to have a slippery grasp on the umbilical cord and vials for collection. These methods pose a risk of exposing Labor and Delivery staff to blood borne diseases. The drainage and milking method can lead to an increased amount of spilled blood while the extraction method may lead to accidental needle sticks. Exposure to bloodborne pathogens may be amplified when the umbilical cord is engorged with blood and as the needle is inserted in the cord, splatter may occur. The Needlestick Safety and Prevention Act was signed into law on November 6, 2000 in which employees were required to implement safer medical devices. Many patents have been obtained for umbilical cord blood collection devices however, there has not been a standardized method of collecting and transferring umbilical cord blood to the laboratory vacuum tubes. The goal of this project is to prove the feasibility of using the Q-Cup, a patent pending disposable, two-piece blood collection and transfer device for safely and efficiently collecting umbilical cord blood and transferring it into laboratory vacuum tubes.
The overall objective of this project is to prove the feasibility of using a two-piece umbilical blood collection and transfer device for safely and effectively collecting umbilical cord blood and transferring the blood into a laboratory vacuum tube. Also, the investigators will assess provider satisfaction, safety, ease of use, length of procedure comparing passive flow into blood tubes and the Q-cup technology. The Q-Cup technology can take part in the effort to reduce occupation exposures including percutaneous exposures during labor and delivery in general and by studying specifically the heretofore neglected category of umbilical cord blood collection and transfer. Efforts in this area will help focus attention on this previously ignored domain and help establish a standard of care and safety during this frequent procedure.
The investigators hypothesize the Q-Cup will be a more effective transfer method than current practices utilized for umbilical cord blood collection.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Texas
-
El Paso, Texas, Forente stater, 79912
- Texas Tech University Health Sciences Center El Paso
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Obstetric patients must be age 18 or older
- Obstetric patients must be receiving prenatal care at Texas Tech University Health Sciences Center El Paso Department of Ob-Gyn
- Obstetric patients must be in their third trimester
- Obstetric patients must be delivering at University Medical Center
Exclusion Criteria:
- children will not be included
- patients in active labor
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Control
The Q-cup will not be used to collect umbilical cord blood.
|
|
|
Aktiv komparator: Study Group
The Q-cup will be used to collect umbilical cord blood.
|
This technology is a different way of collecting umbilical cord blood.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mean Blood Collection Time
Tidsramme: 12 weeks
|
Anticipating the average lengths of cord blood collection with the standard method is 15 seconds and 30 seconds with the Q-cup, we needed 30 subjects total.
15 in the Q-cup arm of the study and 15 in the comparison group (for a two-sided two-sample t-test with 80% power, an alpha of 0.05, and a common standard deviation of 14 seconds).
30 participants were recruited into the study, however, the delivery providers were in charge of collecting this outcome.
|
12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Determining Umbilical Cord Collection Cleanliness With the Q-cup as Compared to the Standard Blood Collection Method
Tidsramme: At Delivery which could be between 1 to 12 weeks after Baseline.
|
Participants' delivery providers were asked to self-administer a survey in which they were to assess blood collection for cleanliness.
Possible choices were excellent/ good or fair/poor.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
At Delivery which could be between 1 to 12 weeks after Baseline.
|
|
Fill Capacity of Umbilical Cord Blood Using the Qcup Compared to Standard of Care
Tidsramme: 12 weeks
|
Participant delivery providers were asked to self-administer a survey in which they were to assess the fill capacity of the lab tubes using the Qcup or the standard method.
Possible choices were filled to capacity and not filled to capacity.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
12 weeks
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Michael Schaffer, MD, Texas Tech University Health Sciences Center, El Paso
Publikasjoner og nyttige lenker
Generelle publikasjoner
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- E17020
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Q-cup
-
Dalhousie UniversityFullført
-
University of AarhusPåmelding etter invitasjonArtroplastikk, hofteproteseDanmark
-
The Cleveland ClinicZimmer BiometFullførtRevisjon, FellesForente stater
-
Stryker Trauma GmbHFullførtLårhodenekrose | Primær artrose | Medfødte dislokasjoner | Lårhalsbrudd | Post-traumatisk artrose av hofte nr
-
Medacta USAFullførtHofteartroseForente stater
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaTilbaketrukketArtrose, hofte
-
University of British ColumbiaNational Research System-College of Family Physicians of CanadaFullført
-
Zimmer BiometAktiv, ikke rekrutterendeLårhalsbrudd | Medfødt hofteleddsdysplasi | Primær artrose | Posttraumatisk leddgikt | Inflammatorisk leddsykdom | Lårhodenekrose | Følgetilstander fra tidligere hofteoperasjoner | OsteotomierFrankrike, Slovenia
-
Rosesta Medical BVFullførtSikkerhetsproblemer | Naturlig unnfangelse | Etikettforståelse | Enhetens brukervennlighetForente stater
-
DePuy InternationalAvsluttetArtrose | Leddgikt | Avaskulær nekrose | Posttraumatisk leddgikt | Medfødt hofteleddsdysplasi | Glidet Capital Femoral Epiphysis | Kollagenforstyrrelser | Traumatiske lårbensbrudd | Ikke-forening av lårbensbruddStorbritannia, Italia